These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2352338)

  • 1. Fat emulsion effects on prothrombin time in warfarin anticoagulated patients: an in vitro study.
    Cotto MA; Lutomski DM; Palascak JE; Fant WK; LaFrance RJ
    JPEN J Parenter Enteral Nutr; 1990; 14(2):201-3. PubMed ID: 2352338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Warfarin resistance associated with intravenous lipid administration.
    Lutomski DM; Palascak JE; Bower RH
    JPEN J Parenter Enteral Nutr; 1987; 11(3):316-8. PubMed ID: 3110450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of heparin on the prothrombin time.
    Schultz NJ; Slaker RA; Rosborough TK
    Pharmacotherapy; 1991; 11(4):312-6. PubMed ID: 1923913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory evidence in support of the currently recommended therapeutic ratio for oral anticoagulant therapy.
    Bradlow BA; Crout FV; Stead A; Adeagbo F
    Hematol Pathol; 1992; 6(1):31-6. PubMed ID: 1601820
    [No Abstract]   [Full Text] [Related]  

  • 5. Association between prothrombin activation fragment (F1.2), cerebral ischemia (S-100beta) and international normalized ratio (INR) in patients with ventricular assisted devices.
    Joshi A; Magder LS; Kon Z; Kallam S; Kwon M; Sangrampurkar R; Pierson R; Poston R
    Interact Cardiovasc Thorac Surg; 2007 Jun; 6(3):323-7. PubMed ID: 17669856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma tissue factor antigen levels in capillary whole blood and venous blood: effect of tissue factor on prothrombin time.
    Quien ET; Morales E; Cisar LA; Kim HC; Cimini C; Saidi P; Philipp CS
    Am J Hematol; 1997 Aug; 55(4):193-8. PubMed ID: 9257879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Warfarin. From bedside to bench.
    Wessler S; Gitel SN
    N Engl J Med; 1984 Sep; 311(10):645-52. PubMed ID: 6472343
    [No Abstract]   [Full Text] [Related]  

  • 8. Variations in prothrombin time and international normalized ratio over 24 hours in warfarin-treated patients.
    Bleske BE; Welage LS; Warren EW; Brown MB; Shea MJ
    Pharmacotherapy; 1995; 15(6):709-12. PubMed ID: 8602377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of lipid emulsion infusion on postmortem ropivacaine concentrations in swine: endeavoring to comprehend a soldier's death.
    Buckenmaier CC; Capacchione J; Mielke AR; Bina S; Shields C; Kwon KH; McKnight G; Fish DA; Bedocs P
    Anesth Analg; 2012 Apr; 114(4):894-900. PubMed ID: 21865498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the native prothrombin antigen and the prothrombin time for monitoring oral anticoagulant therapy.
    Furie B; Liebman HA; Blanchard RA; Coleman MS; Kruger SF; Furie BC
    Blood; 1984 Aug; 64(2):445-51. PubMed ID: 6743826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in the effects of warfarin in dogs by halofenate: an influence upon the kinetics of prothrombin.
    Weintraub M; Griner PF
    Thromb Diath Haemorrh; 1975 Nov; 34(2):445-54. PubMed ID: 1198407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulation control with warfarin by junior hospital doctors.
    Doble N; Baron JH
    J R Soc Med; 1987 Oct; 80(10):627. PubMed ID: 3694600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous fat emulsion acutely suppresses neutrophil chemiluminescence.
    Robin AP; Arain I; Phuangsab A; Holian O; Roccaforte P; Barrett JA
    JPEN J Parenter Enteral Nutr; 1989; 13(6):608-13. PubMed ID: 2515308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of pirmenol administration on the anti-coagulant activity of warfarin.
    Stringer KA; Switzer DF; Abadier R; Lebsack ME; Sedman A; Chrymko M
    J Clin Pharmacol; 1991 Jul; 31(7):607-10. PubMed ID: 1894756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Warfarin and warfarin-alcohol levels in anticoagulated patients.
    Duffield P; Duffield AM; Kennedy M; Birkett DJ; Wade DN
    Aust N Z J Med; 1979 Oct; 9(5):534-7. PubMed ID: 294908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous lipid emulsion only minimally influences bupivacaine and mepivacaine distribution in plasma and does not enhance recovery from intoxication in pigs.
    Litonius ES; Niiya T; Neuvonen PJ; Rosenberg PH
    Anesth Analg; 2012 Apr; 114(4):901-6. PubMed ID: 22025489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [International normalized ratio (INR) for optimal anticoagulant therapy].
    Uetsuka Y; Katsuki T; Aosaki M; Iwade K; Hashimoto A; Koyanagi H; Saito M; Yaginuma Y; Hosoda S
    Kokyu To Junkan; 1993 Sep; 41(9):885-90. PubMed ID: 8210749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prothrombin fragment 1+2 (F1+2), thrombin-antithrombin III complex(TAT) and thrombophilia parameters in orally anticoagulated patients with inferior vena cava filters].
    Halbmayer WM; Haushofer A; Toth E
    Wien Med Wochenschr; 1993; 143(5):95-8. PubMed ID: 8511904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simple technic for predicting daily maintenance dose of warfarin.
    Williams DB; Karl RC
    Am J Surg; 1979 Apr; 137(4):572-6. PubMed ID: 426209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bayesian pharmacokinetic/pharmacodynamic forecasting of prothrombin response to warfarin therapy: preliminary evaluation.
    Svec JM; Coleman RW; Mungall DR; Ludden TM
    Ther Drug Monit; 1985; 7(2):174-80. PubMed ID: 4024210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.